nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—bipolar disorder—Topiramate—obesity	0.254	1	CpDpCtD
Aripiprazole—DRD4—obesity	0.0438	0.169	CbGaD
Aripiprazole—HTR1B—obesity	0.0389	0.151	CbGaD
Aripiprazole—DRD1—obesity	0.0371	0.143	CbGaD
Aripiprazole—ADRB1—obesity	0.0344	0.133	CbGaD
Aripiprazole—HTR2C—obesity	0.0317	0.123	CbGaD
Aripiprazole—SLC6A4—obesity	0.0263	0.102	CbGaD
Aripiprazole—DRD2—obesity	0.0262	0.101	CbGaD
Aripiprazole—SLC6A4—Sibutramine—obesity	0.0237	0.0863	CbGbCtD
Aripiprazole—ADRA1B—Phendimetrazine—obesity	0.0217	0.0791	CbGbCtD
Aripiprazole—HTR2A—obesity	0.0202	0.0781	CbGaD
Aripiprazole—DRD1—Phenylpropanolamine—obesity	0.0196	0.0713	CbGbCtD
Aripiprazole—SLC6A4—Phentermine—obesity	0.0179	0.0654	CbGbCtD
Aripiprazole—ADRA1A—Phendimetrazine—obesity	0.0171	0.0624	CbGbCtD
Aripiprazole—ADRB1—Phenylpropanolamine—obesity	0.0169	0.0615	CbGbCtD
Aripiprazole—ADRA2C—Methamphetamine—obesity	0.0164	0.0598	CbGbCtD
Aripiprazole—ADRA2B—Methamphetamine—obesity	0.0156	0.0567	CbGbCtD
Aripiprazole—SLC6A4—Methamphetamine—obesity	0.0143	0.0523	CbGbCtD
Aripiprazole—ADRA2A—Benzphetamine—obesity	0.0135	0.0493	CbGbCtD
Aripiprazole—ADRA1A—Benzphetamine—obesity	0.013	0.0473	CbGbCtD
Aripiprazole—ADRA2A—Phenylpropanolamine—obesity	0.0129	0.0471	CbGbCtD
Aripiprazole—ADRA1A—Phenylpropanolamine—obesity	0.0124	0.0451	CbGbCtD
Aripiprazole—ADRA2A—Methamphetamine—obesity	0.0108	0.0394	CbGbCtD
Aripiprazole—CYP3A7—Cimetidine—obesity	0.0061	0.0223	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Cimetidine—obesity	0.0061	0.0223	CbGbCtD
Aripiprazole—HTR3A—area postrema—obesity	0.00483	0.176	CbGeAlD
Aripiprazole—CYP3A5—Cimetidine—obesity	0.00458	0.0167	CbGbCtD
Aripiprazole—CYP2D6—Phentermine—obesity	0.0045	0.0164	CbGbCtD
Aripiprazole—CYP2D6—Bupropion—obesity	0.00383	0.014	CbGbCtD
Aripiprazole—CYP3A4—Sibutramine—obesity	0.00378	0.0138	CbGbCtD
Aripiprazole—CYP2D6—Methamphetamine—obesity	0.0036	0.0131	CbGbCtD
Aripiprazole—ABCB1—Cimetidine—obesity	0.00298	0.0109	CbGbCtD
Aripiprazole—CYP3A4—Benzphetamine—obesity	0.00286	0.0104	CbGbCtD
Aripiprazole—CYP2D6—Cimetidine—obesity	0.00281	0.0102	CbGbCtD
Aripiprazole—CYP3A4—Bupropion—obesity	0.00243	0.00887	CbGbCtD
Aripiprazole—CYP3A4—Orlistat—obesity	0.00198	0.00723	CbGbCtD
Aripiprazole—CYP3A4—Cimetidine—obesity	0.00179	0.00651	CbGbCtD
Aripiprazole—HTR3A—vagus nerve—obesity	0.00161	0.0586	CbGeAlD
Aripiprazole—CHRM3—muscle of abdomen—obesity	0.00137	0.0499	CbGeAlD
Aripiprazole—CYP3A4—Topiramate—obesity	0.00117	0.00426	CbGbCtD
Aripiprazole—HTR7—sympathetic nervous system—obesity	0.00108	0.0391	CbGeAlD
Aripiprazole—HTR7—vagus nerve—obesity	0.00104	0.0379	CbGeAlD
Aripiprazole—HTR7—autonomic nervous system—obesity	0.000723	0.0263	CbGeAlD
Aripiprazole—HTR2A—sympathetic nervous system—obesity	0.000671	0.0244	CbGeAlD
Aripiprazole—HTR2A—vagus nerve—obesity	0.00065	0.0236	CbGeAlD
Aripiprazole—HTR2A—autonomic nervous system—obesity	0.000451	0.0164	CbGeAlD
Aripiprazole—SLC6A4—hindbrain—obesity	0.000359	0.0131	CbGeAlD
Aripiprazole—H1F0—islet of Langerhans—obesity	0.000319	0.0116	CbGeAlD
Aripiprazole—HTR1A—hindbrain—obesity	0.000319	0.0116	CbGeAlD
Aripiprazole—HTR7—hindbrain—obesity	0.000305	0.0111	CbGeAlD
Aripiprazole—HTR3A—islet of Langerhans—obesity	0.000305	0.0111	CbGeAlD
Aripiprazole—H1F0—respiratory system—obesity	0.000302	0.011	CbGeAlD
Aripiprazole—ADRA1A—hindbrain—obesity	0.000294	0.0107	CbGeAlD
Aripiprazole—DRD2—hindbrain—obesity	0.000288	0.0105	CbGeAlD
Aripiprazole—HTR3A—respiratory system—obesity	0.000288	0.0105	CbGeAlD
Aripiprazole—H1F0—adrenal cortex—obesity	0.000253	0.00921	CbGeAlD
Aripiprazole—H1F0—cardiovascular system—obesity	0.000231	0.0084	CbGeAlD
Aripiprazole—Vilazodone—SLC6A4—obesity	0.000224	0.118	CrCbGaD
Aripiprazole—Vilazodone—DRD2—obesity	0.000223	0.118	CrCbGaD
Aripiprazole—SLC6A4—respiratory system—obesity	0.000219	0.00798	CbGeAlD
Aripiprazole—CYP3A7—endocrine gland—obesity	0.000214	0.00777	CbGeAlD
Aripiprazole—DRD5—endocrine gland—obesity	0.000205	0.00745	CbGeAlD
Aripiprazole—H1F0—pituitary gland—obesity	0.000205	0.00744	CbGeAlD
Aripiprazole—H1F0—adipose tissue—obesity	0.000204	0.00741	CbGeAlD
Aripiprazole—CYP3A7—liver—obesity	0.000193	0.00701	CbGeAlD
Aripiprazole—H1F0—digestive system—obesity	0.000192	0.00697	CbGeAlD
Aripiprazole—HTR2A—hindbrain—obesity	0.00019	0.00691	CbGeAlD
Aripiprazole—HTR7—respiratory system—obesity	0.000186	0.00677	CbGeAlD
Aripiprazole—HTR1B—cardiovascular system—obesity	0.000185	0.00672	CbGeAlD
Aripiprazole—CHRM2—cardiovascular system—obesity	0.000184	0.00669	CbGeAlD
Aripiprazole—KCNH2—islet of Langerhans—obesity	0.000184	0.00668	CbGeAlD
Aripiprazole—HTR3A—digestive system—obesity	0.000183	0.00665	CbGeAlD
Aripiprazole—H1F0—adrenal gland—obesity	0.000183	0.00665	CbGeAlD
Aripiprazole—HTR2B—adrenal cortex—obesity	0.000182	0.00663	CbGeAlD
Aripiprazole—HTR1D—cardiovascular system—obesity	0.000179	0.00651	CbGeAlD
Aripiprazole—DRD2—respiratory system—obesity	0.000176	0.0064	CbGeAlD
Aripiprazole—ADRB1—cardiovascular system—obesity	0.000174	0.00632	CbGeAlD
Aripiprazole—CYP2D6—hindbrain—obesity	0.000173	0.0063	CbGeAlD
Aripiprazole—CHRM1—cardiovascular system—obesity	0.000167	0.00609	CbGeAlD
Aripiprazole—HTR2B—cardiovascular system—obesity	0.000166	0.00605	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—liver—obesity	0.000164	0.00596	CbGeAlD
Aripiprazole—H1F0—endocrine gland—obesity	0.000158	0.00576	CbGeAlD
Aripiprazole—ADRB1—adipose tissue—obesity	0.000153	0.00558	CbGeAlD
Aripiprazole—CYP3A5—islet of Langerhans—obesity	0.000152	0.00551	CbGeAlD
Aripiprazole—HTR1A—cardiovascular system—obesity	0.000149	0.00542	CbGeAlD
Aripiprazole—HTR2B—adipose tissue—obesity	0.000147	0.00534	CbGeAlD
Aripiprazole—ADRA2A—islet of Langerhans—obesity	0.000145	0.00526	CbGeAlD
Aripiprazole—ADRA2C—adrenal cortex—obesity	0.000144	0.00522	CbGeAlD
Aripiprazole—CYP3A5—respiratory system—obesity	0.000143	0.00521	CbGeAlD
Aripiprazole—H1F0—liver—obesity	0.000143	0.0052	CbGeAlD
Aripiprazole—HTR7—cardiovascular system—obesity	0.000143	0.00518	CbGeAlD
Aripiprazole—Ziprasidone—DRD4—obesity	0.000141	0.0747	CrCbGaD
Aripiprazole—SLC6A4—digestive system—obesity	0.000139	0.00507	CbGeAlD
Aripiprazole—HRH1—respiratory system—obesity	0.000139	0.00505	CbGeAlD
Aripiprazole—HTR2B—digestive system—obesity	0.000138	0.00503	CbGeAlD
Aripiprazole—ADRA1A—cardiovascular system—obesity	0.000137	0.005	CbGeAlD
Aripiprazole—KCNH2—cardiovascular system—obesity	0.000133	0.00483	CbGeAlD
Aripiprazole—CHRM3—adipose tissue—obesity	0.000132	0.0048	CbGeAlD
Aripiprazole—HTR2B—adrenal gland—obesity	0.000132	0.00479	CbGeAlD
Aripiprazole—HTR1B—endocrine gland—obesity	0.000127	0.00461	CbGeAlD
Aripiprazole—CHRM2—endocrine gland—obesity	0.000126	0.00459	CbGeAlD
Aripiprazole—Ziprasidone—HTR1B—obesity	0.000126	0.0663	CrCbGaD
Aripiprazole—CHRM3—digestive system—obesity	0.000124	0.00452	CbGeAlD
Aripiprazole—ADRA1A—adipose tissue—obesity	0.000121	0.00441	CbGeAlD
Aripiprazole—Ziprasidone—DRD1—obesity	0.00012	0.0632	CrCbGaD
Aripiprazole—DRD2—pituitary gland—obesity	0.000119	0.00434	CbGeAlD
Aripiprazole—ADRB1—endocrine gland—obesity	0.000119	0.00434	CbGeAlD
Aripiprazole—HTR7—digestive system—obesity	0.000118	0.0043	CbGeAlD
Aripiprazole—HTR1A—adrenal gland—obesity	0.000118	0.00429	CbGeAlD
Aripiprazole—KCNH2—pituitary gland—obesity	0.000118	0.00428	CbGeAlD
Aripiprazole—HTR2A—respiratory system—obesity	0.000116	0.00422	CbGeAlD
Aripiprazole—ADRA2C—pituitary gland—obesity	0.000116	0.00422	CbGeAlD
Aripiprazole—ADRA2C—adipose tissue—obesity	0.000116	0.0042	CbGeAlD
Aripiprazole—SLC6A4—endocrine gland—obesity	0.000115	0.00419	CbGeAlD
Aripiprazole—CHRM1—endocrine gland—obesity	0.000115	0.00417	CbGeAlD
Aripiprazole—HTR7—adrenal gland—obesity	0.000113	0.0041	CbGeAlD
Aripiprazole—ADRA1A—adrenal gland—obesity	0.000109	0.00396	CbGeAlD
Aripiprazole—KCNH2—adrenal gland—obesity	0.000105	0.00382	CbGeAlD
Aripiprazole—ADRA2C—adrenal gland—obesity	0.000104	0.00377	CbGeAlD
Aripiprazole—CHRM3—endocrine gland—obesity	0.000103	0.00374	CbGeAlD
Aripiprazole—Ziprasidone—HTR2C—obesity	0.000102	0.0541	CrCbGaD
Aripiprazole—HTR1A—endocrine gland—obesity	0.000102	0.00372	CbGeAlD
Aripiprazole—HTR7—endocrine gland—obesity	9.78e-05	0.00356	CbGeAlD
Aripiprazole—CYP3A5—adipose tissue—obesity	9.67e-05	0.00352	CbGeAlD
Aripiprazole—ADRA1A—endocrine gland—obesity	9.43e-05	0.00343	CbGeAlD
Aripiprazole—HRH1—adipose tissue—obesity	9.39e-05	0.00341	CbGeAlD
Aripiprazole—ADRA2A—pituitary gland—obesity	9.26e-05	0.00337	CbGeAlD
Aripiprazole—DRD2—endocrine gland—obesity	9.24e-05	0.00336	CbGeAlD
Aripiprazole—ADRA2A—adipose tissue—obesity	9.22e-05	0.00335	CbGeAlD
Aripiprazole—KCNH2—endocrine gland—obesity	9.11e-05	0.00331	CbGeAlD
Aripiprazole—CYP3A5—digestive system—obesity	9.1e-05	0.00331	CbGeAlD
Aripiprazole—HTR2A—cardiovascular system—obesity	8.89e-05	0.00323	CbGeAlD
Aripiprazole—HRH1—digestive system—obesity	8.83e-05	0.00321	CbGeAlD
Aripiprazole—HTR7—liver—obesity	8.82e-05	0.00321	CbGeAlD
Aripiprazole—Nefazodone—HTR2C—obesity	8.61e-05	0.0454	CrCbGaD
Aripiprazole—ADRA1A—liver—obesity	8.5e-05	0.00309	CbGeAlD
Aripiprazole—Ziprasidone—SLC6A4—obesity	8.48e-05	0.0448	CrCbGaD
Aripiprazole—Ziprasidone—DRD2—obesity	8.44e-05	0.0445	CrCbGaD
Aripiprazole—HRH1—adrenal gland—obesity	8.42e-05	0.00306	CbGeAlD
Aripiprazole—ADRA2A—adrenal gland—obesity	8.27e-05	0.00301	CbGeAlD
Aripiprazole—ADRA2C—liver—obesity	8.1e-05	0.00295	CbGeAlD
Aripiprazole—ABCB1—islet of Langerhans—obesity	8.05e-05	0.00293	CbGeAlD
Aripiprazole—Trazodone—HTR2C—obesity	7.96e-05	0.042	CrCbGaD
Aripiprazole—HTR2A—pituitary gland—obesity	7.87e-05	0.00286	CbGeAlD
Aripiprazole—ABCB1—respiratory system—obesity	7.61e-05	0.00277	CbGeAlD
Aripiprazole—CYP3A5—endocrine gland—obesity	7.52e-05	0.00274	CbGeAlD
Aripiprazole—HTR2A—digestive system—obesity	7.38e-05	0.00268	CbGeAlD
Aripiprazole—HRH1—endocrine gland—obesity	7.3e-05	0.00265	CbGeAlD
Aripiprazole—ADRA2A—endocrine gland—obesity	7.17e-05	0.00261	CbGeAlD
Aripiprazole—Nefazodone—SLC6A4—obesity	7.13e-05	0.0376	CrCbGaD
Aripiprazole—Prochlorperazine—HTR2C—obesity	7.13e-05	0.0376	CrCbGaD
Aripiprazole—HTR2A—adrenal gland—obesity	7.03e-05	0.00256	CbGeAlD
Aripiprazole—CYP3A4—digestive system—obesity	6.83e-05	0.00248	CbGeAlD
Aripiprazole—CYP3A5—liver—obesity	6.78e-05	0.00247	CbGeAlD
Aripiprazole—CYP2D6—digestive system—obesity	6.72e-05	0.00244	CbGeAlD
Aripiprazole—Trazodone—SLC6A4—obesity	6.6e-05	0.0348	CrCbGaD
Aripiprazole—Ziprasidone—HTR2A—obesity	6.52e-05	0.0344	CrCbGaD
Aripiprazole—ABCB1—adrenal cortex—obesity	6.38e-05	0.00232	CbGeAlD
Aripiprazole—HTR2A—endocrine gland—obesity	6.1e-05	0.00222	CbGeAlD
Aripiprazole—Perphenazine—DRD1—obesity	5.96e-05	0.0315	CrCbGaD
Aripiprazole—Prochlorperazine—DRD2—obesity	5.88e-05	0.031	CrCbGaD
Aripiprazole—ABCB1—cardiovascular system—obesity	5.83e-05	0.00212	CbGeAlD
Aripiprazole—CYP3A4—endocrine gland—obesity	5.64e-05	0.00205	CbGeAlD
Aripiprazole—CYP2D6—endocrine gland—obesity	5.55e-05	0.00202	CbGeAlD
Aripiprazole—HTR2A—liver—obesity	5.5e-05	0.002	CbGeAlD
Aripiprazole—Nefazodone—HTR2A—obesity	5.48e-05	0.0289	CrCbGaD
Aripiprazole—ABCB1—pituitary gland—obesity	5.16e-05	0.00188	CbGeAlD
Aripiprazole—ABCB1—adipose tissue—obesity	5.14e-05	0.00187	CbGeAlD
Aripiprazole—Perphenazine—HTR2C—obesity	5.1e-05	0.0269	CrCbGaD
Aripiprazole—CYP3A4—liver—obesity	5.09e-05	0.00185	CbGeAlD
Aripiprazole—Trazodone—HTR2A—obesity	5.07e-05	0.0268	CrCbGaD
Aripiprazole—CYP2D6—liver—obesity	5.01e-05	0.00182	CbGeAlD
Aripiprazole—ABCB1—digestive system—obesity	4.84e-05	0.00176	CbGeAlD
Aripiprazole—ABCB1—adrenal gland—obesity	4.61e-05	0.00168	CbGeAlD
Aripiprazole—Perphenazine—DRD2—obesity	4.2e-05	0.0222	CrCbGaD
Aripiprazole—ABCB1—endocrine gland—obesity	4e-05	0.00145	CbGeAlD
Aripiprazole—ABCB1—liver—obesity	3.6e-05	0.00131	CbGeAlD
Aripiprazole—Perphenazine—HTR2A—obesity	3.25e-05	0.0171	CrCbGaD
Aripiprazole—Hypokalaemia—Topiramate—obesity	2.48e-05	0.000236	CcSEcCtD
Aripiprazole—Muscle spasms—Bupropion—obesity	2.48e-05	0.000236	CcSEcCtD
Aripiprazole—Infection—Orlistat—obesity	2.48e-05	0.000236	CcSEcCtD
Aripiprazole—Breast disorder—Topiramate—obesity	2.46e-05	0.000235	CcSEcCtD
Aripiprazole—Dry mouth—Sibutramine—obesity	2.46e-05	0.000234	CcSEcCtD
Aripiprazole—Aspartate aminotransferase increased—Topiramate—obesity	2.45e-05	0.000234	CcSEcCtD
Aripiprazole—Nervous system disorder—Orlistat—obesity	2.44e-05	0.000233	CcSEcCtD
Aripiprazole—Nasopharyngitis—Topiramate—obesity	2.44e-05	0.000232	CcSEcCtD
Aripiprazole—Confusional state—Sibutramine—obesity	2.43e-05	0.000232	CcSEcCtD
Aripiprazole—Vision blurred—Bupropion—obesity	2.43e-05	0.000231	CcSEcCtD
Aripiprazole—Skin disorder—Orlistat—obesity	2.42e-05	0.000231	CcSEcCtD
Aripiprazole—Tremor—Bupropion—obesity	2.41e-05	0.00023	CcSEcCtD
Aripiprazole—Gastritis—Topiramate—obesity	2.41e-05	0.00023	CcSEcCtD
Aripiprazole—Oedema—Sibutramine—obesity	2.41e-05	0.00023	CcSEcCtD
Aripiprazole—Anaphylactic shock—Sibutramine—obesity	2.41e-05	0.00023	CcSEcCtD
Aripiprazole—Hyperhidrosis—Orlistat—obesity	2.41e-05	0.000229	CcSEcCtD
Aripiprazole—Alanine aminotransferase increased—Topiramate—obesity	2.4e-05	0.000229	CcSEcCtD
Aripiprazole—Muscular weakness—Topiramate—obesity	2.4e-05	0.000229	CcSEcCtD
Aripiprazole—Infection—Sibutramine—obesity	2.4e-05	0.000228	CcSEcCtD
Aripiprazole—Ill-defined disorder—Bupropion—obesity	2.39e-05	0.000228	CcSEcCtD
Aripiprazole—Anaemia—Bupropion—obesity	2.38e-05	0.000227	CcSEcCtD
Aripiprazole—Shock—Sibutramine—obesity	2.37e-05	0.000226	CcSEcCtD
Aripiprazole—Abdominal distension—Topiramate—obesity	2.37e-05	0.000226	CcSEcCtD
Aripiprazole—Agitation—Bupropion—obesity	2.37e-05	0.000225	CcSEcCtD
Aripiprazole—Thrombocytopenia—Sibutramine—obesity	2.36e-05	0.000225	CcSEcCtD
Aripiprazole—Dysphagia—Topiramate—obesity	2.36e-05	0.000224	CcSEcCtD
Aripiprazole—Asthma—Topiramate—obesity	2.36e-05	0.000224	CcSEcCtD
Aripiprazole—Angioedema—Bupropion—obesity	2.35e-05	0.000224	CcSEcCtD
Aripiprazole—Tachycardia—Sibutramine—obesity	2.35e-05	0.000224	CcSEcCtD
Aripiprazole—Skin disorder—Sibutramine—obesity	2.34e-05	0.000223	CcSEcCtD
Aripiprazole—Eosinophilia—Topiramate—obesity	2.33e-05	0.000222	CcSEcCtD
Aripiprazole—Hyperhidrosis—Sibutramine—obesity	2.33e-05	0.000222	CcSEcCtD
Aripiprazole—Malaise—Bupropion—obesity	2.32e-05	0.000221	CcSEcCtD
Aripiprazole—Vertigo—Bupropion—obesity	2.31e-05	0.00022	CcSEcCtD
Aripiprazole—Syncope—Bupropion—obesity	2.31e-05	0.00022	CcSEcCtD
Aripiprazole—Pancreatitis—Topiramate—obesity	2.31e-05	0.00022	CcSEcCtD
Aripiprazole—Leukopenia—Bupropion—obesity	2.31e-05	0.00022	CcSEcCtD
Aripiprazole—Anorexia—Sibutramine—obesity	2.3e-05	0.000219	CcSEcCtD
Aripiprazole—Angina pectoris—Topiramate—obesity	2.29e-05	0.000219	CcSEcCtD
Aripiprazole—Palpitations—Bupropion—obesity	2.28e-05	0.000217	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Orlistat—obesity	2.27e-05	0.000216	CcSEcCtD
Aripiprazole—Loss of consciousness—Bupropion—obesity	2.26e-05	0.000216	CcSEcCtD
Aripiprazole—Abdominal discomfort—Topiramate—obesity	2.26e-05	0.000215	CcSEcCtD
Aripiprazole—Insomnia—Orlistat—obesity	2.25e-05	0.000215	CcSEcCtD
Aripiprazole—Hypotension—Sibutramine—obesity	2.25e-05	0.000215	CcSEcCtD
Aripiprazole—Cough—Bupropion—obesity	2.25e-05	0.000214	CcSEcCtD
Aripiprazole—Paraesthesia—Orlistat—obesity	2.24e-05	0.000213	CcSEcCtD
Aripiprazole—Convulsion—Bupropion—obesity	2.23e-05	0.000213	CcSEcCtD
Aripiprazole—Hypertension—Bupropion—obesity	2.22e-05	0.000212	CcSEcCtD
Aripiprazole—Dysuria—Topiramate—obesity	2.2e-05	0.00021	CcSEcCtD
Aripiprazole—Neutropenia—Topiramate—obesity	2.2e-05	0.00021	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Sibutramine—obesity	2.2e-05	0.000209	CcSEcCtD
Aripiprazole—Dyspepsia—Orlistat—obesity	2.19e-05	0.000209	CcSEcCtD
Aripiprazole—Arthralgia—Bupropion—obesity	2.19e-05	0.000209	CcSEcCtD
Aripiprazole—Myalgia—Bupropion—obesity	2.19e-05	0.000209	CcSEcCtD
Aripiprazole—Chest pain—Bupropion—obesity	2.19e-05	0.000209	CcSEcCtD
Aripiprazole—Upper respiratory tract infection—Topiramate—obesity	2.19e-05	0.000209	CcSEcCtD
Aripiprazole—Anxiety—Bupropion—obesity	2.19e-05	0.000208	CcSEcCtD
Aripiprazole—Insomnia—Sibutramine—obesity	2.18e-05	0.000208	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	2.18e-05	0.000207	CcSEcCtD
Aripiprazole—Pollakiuria—Topiramate—obesity	2.18e-05	0.000207	CcSEcCtD
Aripiprazole—Erectile dysfunction—Topiramate—obesity	2.17e-05	0.000207	CcSEcCtD
Aripiprazole—Discomfort—Bupropion—obesity	2.17e-05	0.000206	CcSEcCtD
Aripiprazole—Decreased appetite—Orlistat—obesity	2.17e-05	0.000206	CcSEcCtD
Aripiprazole—Paraesthesia—Sibutramine—obesity	2.17e-05	0.000206	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Orlistat—obesity	2.15e-05	0.000205	CcSEcCtD
Aripiprazole—Dyspnoea—Sibutramine—obesity	2.15e-05	0.000205	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Topiramate—obesity	2.15e-05	0.000205	CcSEcCtD
Aripiprazole—Fatigue—Orlistat—obesity	2.15e-05	0.000205	CcSEcCtD
Aripiprazole—Dry mouth—Bupropion—obesity	2.14e-05	0.000204	CcSEcCtD
Aripiprazole—Somnolence—Sibutramine—obesity	2.14e-05	0.000204	CcSEcCtD
Aripiprazole—Weight increased—Topiramate—obesity	2.14e-05	0.000204	CcSEcCtD
Aripiprazole—Weight decreased—Topiramate—obesity	2.13e-05	0.000203	CcSEcCtD
Aripiprazole—Pain—Orlistat—obesity	2.13e-05	0.000203	CcSEcCtD
Aripiprazole—Hyperglycaemia—Topiramate—obesity	2.12e-05	0.000202	CcSEcCtD
Aripiprazole—Dyspepsia—Sibutramine—obesity	2.12e-05	0.000202	CcSEcCtD
Aripiprazole—Confusional state—Bupropion—obesity	2.12e-05	0.000202	CcSEcCtD
Aripiprazole—Pneumonia—Topiramate—obesity	2.11e-05	0.000201	CcSEcCtD
Aripiprazole—Oedema—Bupropion—obesity	2.1e-05	0.0002	CcSEcCtD
Aripiprazole—Anaphylactic shock—Bupropion—obesity	2.1e-05	0.0002	CcSEcCtD
Aripiprazole—Infestation—Topiramate—obesity	2.1e-05	0.0002	CcSEcCtD
Aripiprazole—Infestation NOS—Topiramate—obesity	2.1e-05	0.0002	CcSEcCtD
Aripiprazole—Decreased appetite—Sibutramine—obesity	2.1e-05	0.0002	CcSEcCtD
Aripiprazole—Depression—Topiramate—obesity	2.09e-05	0.000199	CcSEcCtD
Aripiprazole—Infection—Bupropion—obesity	2.09e-05	0.000199	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Sibutramine—obesity	2.08e-05	0.000198	CcSEcCtD
Aripiprazole—Shock—Bupropion—obesity	2.07e-05	0.000197	CcSEcCtD
Aripiprazole—Renal failure—Topiramate—obesity	2.06e-05	0.000197	CcSEcCtD
Aripiprazole—Constipation—Sibutramine—obesity	2.06e-05	0.000196	CcSEcCtD
Aripiprazole—Pain—Sibutramine—obesity	2.06e-05	0.000196	CcSEcCtD
Aripiprazole—Nervous system disorder—Bupropion—obesity	2.06e-05	0.000196	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Topiramate—obesity	2.06e-05	0.000196	CcSEcCtD
Aripiprazole—Thrombocytopenia—Bupropion—obesity	2.06e-05	0.000196	CcSEcCtD
Aripiprazole—Feeling abnormal—Orlistat—obesity	2.05e-05	0.000196	CcSEcCtD
Aripiprazole—Tachycardia—Bupropion—obesity	2.05e-05	0.000195	CcSEcCtD
Aripiprazole—Stomatitis—Topiramate—obesity	2.05e-05	0.000195	CcSEcCtD
Aripiprazole—Skin disorder—Bupropion—obesity	2.04e-05	0.000195	CcSEcCtD
Aripiprazole—Conjunctivitis—Topiramate—obesity	2.04e-05	0.000194	CcSEcCtD
Aripiprazole—Urinary tract infection—Topiramate—obesity	2.04e-05	0.000194	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Orlistat—obesity	2.04e-05	0.000194	CcSEcCtD
Aripiprazole—Hyperhidrosis—Bupropion—obesity	2.03e-05	0.000194	CcSEcCtD
Aripiprazole—Anorexia—Bupropion—obesity	2e-05	0.000191	CcSEcCtD
Aripiprazole—Haematuria—Topiramate—obesity	2e-05	0.000191	CcSEcCtD
Aripiprazole—Feeling abnormal—Sibutramine—obesity	1.99e-05	0.000189	CcSEcCtD
Aripiprazole—Epistaxis—Topiramate—obesity	1.98e-05	0.000189	CcSEcCtD
Aripiprazole—Urticaria—Orlistat—obesity	1.98e-05	0.000189	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Sibutramine—obesity	1.97e-05	0.000188	CcSEcCtD
Aripiprazole—Sinusitis—Topiramate—obesity	1.97e-05	0.000188	CcSEcCtD
Aripiprazole—Abdominal pain—Orlistat—obesity	1.97e-05	0.000188	CcSEcCtD
Aripiprazole—Body temperature increased—Orlistat—obesity	1.97e-05	0.000188	CcSEcCtD
Aripiprazole—Hypotension—Bupropion—obesity	1.96e-05	0.000187	CcSEcCtD
Aripiprazole—Agranulocytosis—Topiramate—obesity	1.96e-05	0.000187	CcSEcCtD
Aripiprazole—Bradycardia—Topiramate—obesity	1.92e-05	0.000183	CcSEcCtD
Aripiprazole—Urticaria—Sibutramine—obesity	1.92e-05	0.000182	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Bupropion—obesity	1.92e-05	0.000182	CcSEcCtD
Aripiprazole—Abdominal pain—Sibutramine—obesity	1.91e-05	0.000182	CcSEcCtD
Aripiprazole—Body temperature increased—Sibutramine—obesity	1.91e-05	0.000182	CcSEcCtD
Aripiprazole—Insomnia—Bupropion—obesity	1.9e-05	0.000181	CcSEcCtD
Aripiprazole—Haemoglobin—Topiramate—obesity	1.89e-05	0.00018	CcSEcCtD
Aripiprazole—Rhinitis—Topiramate—obesity	1.89e-05	0.00018	CcSEcCtD
Aripiprazole—Paraesthesia—Bupropion—obesity	1.89e-05	0.00018	CcSEcCtD
Aripiprazole—Haemorrhage—Topiramate—obesity	1.89e-05	0.00018	CcSEcCtD
Aripiprazole—Hepatitis—Topiramate—obesity	1.89e-05	0.00018	CcSEcCtD
Aripiprazole—Hypoaesthesia—Topiramate—obesity	1.88e-05	0.000179	CcSEcCtD
Aripiprazole—Hallucination—Topiramate—obesity	1.88e-05	0.000179	CcSEcCtD
Aripiprazole—Dyspnoea—Bupropion—obesity	1.87e-05	0.000179	CcSEcCtD
Aripiprazole—Pharyngitis—Topiramate—obesity	1.87e-05	0.000178	CcSEcCtD
Aripiprazole—Somnolence—Bupropion—obesity	1.87e-05	0.000178	CcSEcCtD
Aripiprazole—Urinary tract disorder—Topiramate—obesity	1.86e-05	0.000177	CcSEcCtD
Aripiprazole—Oedema peripheral—Topiramate—obesity	1.86e-05	0.000177	CcSEcCtD
Aripiprazole—Connective tissue disorder—Topiramate—obesity	1.85e-05	0.000176	CcSEcCtD
Aripiprazole—Dyspepsia—Bupropion—obesity	1.85e-05	0.000176	CcSEcCtD
Aripiprazole—Urethral disorder—Topiramate—obesity	1.85e-05	0.000176	CcSEcCtD
Aripiprazole—Hypersensitivity—Orlistat—obesity	1.84e-05	0.000175	CcSEcCtD
Aripiprazole—Decreased appetite—Bupropion—obesity	1.83e-05	0.000174	CcSEcCtD
Aripiprazole—Visual impairment—Topiramate—obesity	1.82e-05	0.000173	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Bupropion—obesity	1.81e-05	0.000173	CcSEcCtD
Aripiprazole—Fatigue—Bupropion—obesity	1.81e-05	0.000173	CcSEcCtD
Aripiprazole—Pain—Bupropion—obesity	1.8e-05	0.000171	CcSEcCtD
Aripiprazole—Constipation—Bupropion—obesity	1.8e-05	0.000171	CcSEcCtD
Aripiprazole—Asthenia—Orlistat—obesity	1.79e-05	0.00017	CcSEcCtD
Aripiprazole—Hypersensitivity—Sibutramine—obesity	1.78e-05	0.000169	CcSEcCtD
Aripiprazole—Pruritus—Orlistat—obesity	1.76e-05	0.000168	CcSEcCtD
Aripiprazole—Eye disorder—Topiramate—obesity	1.76e-05	0.000168	CcSEcCtD
Aripiprazole—Tinnitus—Topiramate—obesity	1.76e-05	0.000167	CcSEcCtD
Aripiprazole—Flushing—Topiramate—obesity	1.75e-05	0.000167	CcSEcCtD
Aripiprazole—Cardiac disorder—Topiramate—obesity	1.75e-05	0.000167	CcSEcCtD
Aripiprazole—Feeling abnormal—Bupropion—obesity	1.73e-05	0.000165	CcSEcCtD
Aripiprazole—Asthenia—Sibutramine—obesity	1.73e-05	0.000165	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Bupropion—obesity	1.72e-05	0.000164	CcSEcCtD
Aripiprazole—Angiopathy—Topiramate—obesity	1.71e-05	0.000163	CcSEcCtD
Aripiprazole—Pruritus—Sibutramine—obesity	1.71e-05	0.000163	CcSEcCtD
Aripiprazole—Diarrhoea—Orlistat—obesity	1.7e-05	0.000162	CcSEcCtD
Aripiprazole—Immune system disorder—Topiramate—obesity	1.7e-05	0.000162	CcSEcCtD
Aripiprazole—Mediastinal disorder—Topiramate—obesity	1.7e-05	0.000162	CcSEcCtD
Aripiprazole—Chills—Topiramate—obesity	1.69e-05	0.000161	CcSEcCtD
Aripiprazole—Urticaria—Bupropion—obesity	1.67e-05	0.000159	CcSEcCtD
Aripiprazole—Alopecia—Topiramate—obesity	1.67e-05	0.000159	CcSEcCtD
Aripiprazole—Abdominal pain—Bupropion—obesity	1.66e-05	0.000158	CcSEcCtD
Aripiprazole—Body temperature increased—Bupropion—obesity	1.66e-05	0.000158	CcSEcCtD
Aripiprazole—Mental disorder—Topiramate—obesity	1.65e-05	0.000157	CcSEcCtD
Aripiprazole—Diarrhoea—Sibutramine—obesity	1.65e-05	0.000157	CcSEcCtD
Aripiprazole—Dizziness—Orlistat—obesity	1.65e-05	0.000157	CcSEcCtD
Aripiprazole—Malnutrition—Topiramate—obesity	1.64e-05	0.000156	CcSEcCtD
Aripiprazole—Erythema—Topiramate—obesity	1.64e-05	0.000156	CcSEcCtD
Aripiprazole—Flatulence—Topiramate—obesity	1.62e-05	0.000154	CcSEcCtD
Aripiprazole—Tension—Topiramate—obesity	1.61e-05	0.000153	CcSEcCtD
Aripiprazole—Dysgeusia—Topiramate—obesity	1.61e-05	0.000153	CcSEcCtD
Aripiprazole—Dizziness—Sibutramine—obesity	1.59e-05	0.000152	CcSEcCtD
Aripiprazole—Nervousness—Topiramate—obesity	1.59e-05	0.000152	CcSEcCtD
Aripiprazole—Back pain—Topiramate—obesity	1.59e-05	0.000151	CcSEcCtD
Aripiprazole—Vomiting—Orlistat—obesity	1.58e-05	0.000151	CcSEcCtD
Aripiprazole—Muscle spasms—Topiramate—obesity	1.58e-05	0.00015	CcSEcCtD
Aripiprazole—Rash—Orlistat—obesity	1.57e-05	0.00015	CcSEcCtD
Aripiprazole—Dermatitis—Orlistat—obesity	1.57e-05	0.00015	CcSEcCtD
Aripiprazole—Headache—Orlistat—obesity	1.56e-05	0.000149	CcSEcCtD
Aripiprazole—Hypersensitivity—Bupropion—obesity	1.55e-05	0.000148	CcSEcCtD
Aripiprazole—Vision blurred—Topiramate—obesity	1.55e-05	0.000147	CcSEcCtD
Aripiprazole—Tremor—Topiramate—obesity	1.54e-05	0.000146	CcSEcCtD
Aripiprazole—Vomiting—Sibutramine—obesity	1.53e-05	0.000146	CcSEcCtD
Aripiprazole—Ill-defined disorder—Topiramate—obesity	1.52e-05	0.000145	CcSEcCtD
Aripiprazole—Rash—Sibutramine—obesity	1.52e-05	0.000145	CcSEcCtD
Aripiprazole—Dermatitis—Sibutramine—obesity	1.52e-05	0.000145	CcSEcCtD
Aripiprazole—Anaemia—Topiramate—obesity	1.52e-05	0.000144	CcSEcCtD
Aripiprazole—Headache—Sibutramine—obesity	1.51e-05	0.000144	CcSEcCtD
Aripiprazole—Asthenia—Bupropion—obesity	1.51e-05	0.000144	CcSEcCtD
Aripiprazole—Agitation—Topiramate—obesity	1.51e-05	0.000144	CcSEcCtD
Aripiprazole—Pruritus—Bupropion—obesity	1.49e-05	0.000142	CcSEcCtD
Aripiprazole—Nausea—Orlistat—obesity	1.48e-05	0.000141	CcSEcCtD
Aripiprazole—Malaise—Topiramate—obesity	1.48e-05	0.000141	CcSEcCtD
Aripiprazole—Vertigo—Topiramate—obesity	1.47e-05	0.00014	CcSEcCtD
Aripiprazole—Syncope—Topiramate—obesity	1.47e-05	0.00014	CcSEcCtD
Aripiprazole—Leukopenia—Topiramate—obesity	1.47e-05	0.00014	CcSEcCtD
Aripiprazole—Palpitations—Topiramate—obesity	1.45e-05	0.000138	CcSEcCtD
Aripiprazole—Loss of consciousness—Topiramate—obesity	1.44e-05	0.000137	CcSEcCtD
Aripiprazole—Diarrhoea—Bupropion—obesity	1.44e-05	0.000137	CcSEcCtD
Aripiprazole—Nausea—Sibutramine—obesity	1.43e-05	0.000136	CcSEcCtD
Aripiprazole—Cough—Topiramate—obesity	1.43e-05	0.000136	CcSEcCtD
Aripiprazole—Convulsion—Topiramate—obesity	1.42e-05	0.000135	CcSEcCtD
Aripiprazole—Hypertension—Topiramate—obesity	1.42e-05	0.000135	CcSEcCtD
Aripiprazole—Myalgia—Topiramate—obesity	1.4e-05	0.000133	CcSEcCtD
Aripiprazole—Chest pain—Topiramate—obesity	1.4e-05	0.000133	CcSEcCtD
Aripiprazole—Arthralgia—Topiramate—obesity	1.4e-05	0.000133	CcSEcCtD
Aripiprazole—Anxiety—Topiramate—obesity	1.39e-05	0.000133	CcSEcCtD
Aripiprazole—Dizziness—Bupropion—obesity	1.39e-05	0.000132	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	1.39e-05	0.000132	CcSEcCtD
Aripiprazole—Discomfort—Topiramate—obesity	1.38e-05	0.000131	CcSEcCtD
Aripiprazole—Dry mouth—Topiramate—obesity	1.37e-05	0.00013	CcSEcCtD
Aripiprazole—Confusional state—Topiramate—obesity	1.35e-05	0.000129	CcSEcCtD
Aripiprazole—Oedema—Topiramate—obesity	1.34e-05	0.000128	CcSEcCtD
Aripiprazole—Vomiting—Bupropion—obesity	1.34e-05	0.000127	CcSEcCtD
Aripiprazole—Infection—Topiramate—obesity	1.33e-05	0.000127	CcSEcCtD
Aripiprazole—Rash—Bupropion—obesity	1.33e-05	0.000126	CcSEcCtD
Aripiprazole—Dermatitis—Bupropion—obesity	1.32e-05	0.000126	CcSEcCtD
Aripiprazole—Shock—Topiramate—obesity	1.32e-05	0.000126	CcSEcCtD
Aripiprazole—Headache—Bupropion—obesity	1.32e-05	0.000125	CcSEcCtD
Aripiprazole—Nervous system disorder—Topiramate—obesity	1.31e-05	0.000125	CcSEcCtD
Aripiprazole—Thrombocytopenia—Topiramate—obesity	1.31e-05	0.000125	CcSEcCtD
Aripiprazole—Tachycardia—Topiramate—obesity	1.31e-05	0.000125	CcSEcCtD
Aripiprazole—Skin disorder—Topiramate—obesity	1.3e-05	0.000124	CcSEcCtD
Aripiprazole—Hyperhidrosis—Topiramate—obesity	1.29e-05	0.000123	CcSEcCtD
Aripiprazole—Anorexia—Topiramate—obesity	1.28e-05	0.000122	CcSEcCtD
Aripiprazole—Hypotension—Topiramate—obesity	1.25e-05	0.000119	CcSEcCtD
Aripiprazole—Nausea—Bupropion—obesity	1.25e-05	0.000119	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Topiramate—obesity	1.22e-05	0.000116	CcSEcCtD
Aripiprazole—Insomnia—Topiramate—obesity	1.21e-05	0.000115	CcSEcCtD
Aripiprazole—Paraesthesia—Topiramate—obesity	1.2e-05	0.000115	CcSEcCtD
Aripiprazole—Dyspnoea—Topiramate—obesity	1.19e-05	0.000114	CcSEcCtD
Aripiprazole—Somnolence—Topiramate—obesity	1.19e-05	0.000113	CcSEcCtD
Aripiprazole—Dyspepsia—Topiramate—obesity	1.18e-05	0.000112	CcSEcCtD
Aripiprazole—Decreased appetite—Topiramate—obesity	1.16e-05	0.000111	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Topiramate—obesity	1.16e-05	0.00011	CcSEcCtD
Aripiprazole—Fatigue—Topiramate—obesity	1.15e-05	0.00011	CcSEcCtD
Aripiprazole—Constipation—Topiramate—obesity	1.15e-05	0.000109	CcSEcCtD
Aripiprazole—Pain—Topiramate—obesity	1.15e-05	0.000109	CcSEcCtD
Aripiprazole—Feeling abnormal—Topiramate—obesity	1.1e-05	0.000105	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Topiramate—obesity	1.1e-05	0.000104	CcSEcCtD
Aripiprazole—Urticaria—Topiramate—obesity	1.06e-05	0.000101	CcSEcCtD
Aripiprazole—Abdominal pain—Topiramate—obesity	1.06e-05	0.000101	CcSEcCtD
Aripiprazole—Body temperature increased—Topiramate—obesity	1.06e-05	0.000101	CcSEcCtD
Aripiprazole—Hypersensitivity—Topiramate—obesity	9.87e-06	9.4e-05	CcSEcCtD
Aripiprazole—Asthenia—Topiramate—obesity	9.61e-06	9.15e-05	CcSEcCtD
Aripiprazole—Pruritus—Topiramate—obesity	9.47e-06	9.03e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Topiramate—obesity	9.16e-06	8.73e-05	CcSEcCtD
Aripiprazole—Dizziness—Topiramate—obesity	8.86e-06	8.44e-05	CcSEcCtD
Aripiprazole—Vomiting—Topiramate—obesity	8.52e-06	8.11e-05	CcSEcCtD
Aripiprazole—Rash—Topiramate—obesity	8.44e-06	8.04e-05	CcSEcCtD
Aripiprazole—Dermatitis—Topiramate—obesity	8.44e-06	8.04e-05	CcSEcCtD
Aripiprazole—Headache—Topiramate—obesity	8.39e-06	7.99e-05	CcSEcCtD
Aripiprazole—Nausea—Topiramate—obesity	7.95e-06	7.58e-05	CcSEcCtD
Aripiprazole—CYP3A5—Metabolism—PIK3CB—obesity	3.82e-07	4.87e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—RHOA—obesity	3.82e-07	4.87e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MTOR—obesity	3.81e-07	4.86e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PIK3CB—obesity	3.81e-07	4.86e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PIK3CB—obesity	3.8e-07	4.85e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MTOR—obesity	3.8e-07	4.85e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—obesity	3.79e-07	4.83e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GGT1—obesity	3.78e-07	4.82e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GOT1—obesity	3.78e-07	4.82e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3R1—obesity	3.78e-07	4.82e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NOS3—obesity	3.78e-07	4.82e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CG—obesity	3.76e-07	4.8e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MTOR—obesity	3.76e-07	4.8e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PIK3CB—obesity	3.76e-07	4.8e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MTOR—obesity	3.75e-07	4.79e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PIK3CB—obesity	3.75e-07	4.79e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK8—obesity	3.75e-07	4.78e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—AKT1—obesity	3.74e-07	4.77e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MMP9—obesity	3.73e-07	4.76e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK8—obesity	3.73e-07	4.76e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NCOA1—obesity	3.73e-07	4.75e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—AKT1—obesity	3.72e-07	4.74e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MYC—obesity	3.71e-07	4.72e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—obesity	3.7e-07	4.71e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MMP9—obesity	3.67e-07	4.68e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CYP19A1—obesity	3.67e-07	4.68e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—STK11—obesity	3.67e-07	4.68e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MYC—obesity	3.66e-07	4.66e-06	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—PIK3CA—obesity	3.65e-07	4.66e-06	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—PIK3CA—obesity	3.65e-07	4.65e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—obesity	3.65e-07	4.65e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PPARG—obesity	3.63e-07	4.63e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK8—obesity	3.63e-07	4.63e-06	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—PIK3CA—obesity	3.63e-07	4.62e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—AKT1—obesity	3.62e-07	4.62e-06	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—AKT1—obesity	3.62e-07	4.61e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—PIK3CA—obesity	3.6e-07	4.59e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—STAT3—obesity	3.58e-07	4.57e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—POMC—obesity	3.58e-07	4.57e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK8—obesity	3.57e-07	4.55e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—INS—obesity	3.56e-07	4.54e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—AKT1—obesity	3.56e-07	4.54e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—obesity	3.56e-07	4.54e-06	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—AKT1—obesity	3.56e-07	4.54e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—STAT3—obesity	3.55e-07	4.53e-06	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—AKT1—obesity	3.55e-07	4.53e-06	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—PIK3CA—obesity	3.55e-07	4.53e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CG—obesity	3.55e-07	4.52e-06	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—AKT1—obesity	3.54e-07	4.51e-06	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—AKT1—obesity	3.53e-07	4.5e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—obesity	3.5e-07	4.47e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—obesity	3.5e-07	4.46e-06	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—PIK3CA—obesity	3.49e-07	4.46e-06	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—AKT1—obesity	3.49e-07	4.45e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MTOR—obesity	3.49e-07	4.45e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3CB—obesity	3.49e-07	4.45e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—AKT1—obesity	3.48e-07	4.44e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—obesity	3.48e-07	4.44e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—obesity	3.47e-07	4.43e-06	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—PIK3CA—obesity	3.45e-07	4.4e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—obesity	3.44e-07	4.39e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—obesity	3.43e-07	4.37e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—STAT3—obesity	3.43e-07	4.37e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARG—obesity	3.42e-07	4.36e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—COMT—obesity	3.41e-07	4.35e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—STAT3—obesity	3.41e-07	4.35e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MMP9—obesity	3.39e-07	4.32e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—POMC—obesity	3.38e-07	4.3e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GNB3—obesity	3.37e-07	4.29e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARGC1A—obesity	3.37e-07	4.29e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—INS—obesity	3.36e-07	4.28e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—HMOX1—obesity	3.35e-07	4.27e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—PIK3CA—obesity	3.34e-07	4.25e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MMP9—obesity	3.33e-07	4.25e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MYC—obesity	3.33e-07	4.25e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MMP9—obesity	3.32e-07	4.24e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—obesity	3.32e-07	4.24e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—STAT3—obesity	3.32e-07	4.23e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MMP9—obesity	3.31e-07	4.23e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CD—obesity	3.31e-07	4.22e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MMP9—obesity	3.3e-07	4.21e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—PIK3CA—obesity	3.3e-07	4.21e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MYC—obesity	3.3e-07	4.21e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK8—obesity	3.29e-07	4.2e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—obesity	3.29e-07	4.2e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—AKT1—obesity	3.28e-07	4.19e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GNAS—obesity	3.28e-07	4.18e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MMP9—obesity	3.27e-07	4.17e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—obesity	3.27e-07	4.16e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—STAT3—obesity	3.27e-07	4.16e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—obesity	3.26e-07	4.16e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK8—obesity	3.24e-07	4.13e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AKT1—obesity	3.24e-07	4.13e-06	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—obesity	3.24e-07	4.13e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK8—obesity	3.23e-07	4.12e-06	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—obesity	3.23e-07	4.12e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AKT1—obesity	3.23e-07	4.12e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AKT1—obesity	3.22e-07	4.11e-06	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—PIK3CA—obesity	3.22e-07	4.11e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK8—obesity	3.22e-07	4.11e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AKT1—obesity	3.21e-07	4.1e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK8—obesity	3.21e-07	4.1e-06	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—obesity	3.21e-07	4.09e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOB—obesity	3.21e-07	4.09e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AKT1—obesity	3.2e-07	4.09e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—obesity	3.19e-07	4.06e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MYC—obesity	3.19e-07	4.06e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK8—obesity	3.18e-07	4.06e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—obesity	3.18e-07	4.05e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AKT1—obesity	3.17e-07	4.05e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK8—obesity	3.17e-07	4.05e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MYC—obesity	3.17e-07	4.04e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AKT1—obesity	3.16e-07	4.03e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—obesity	3.16e-07	4.03e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—PIK3CA—obesity	3.15e-07	4.01e-06	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—obesity	3.14e-07	4.01e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PIK3CA—obesity	3.13e-07	3.99e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—NOS3—obesity	3.12e-07	3.98e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3R1—obesity	3.12e-07	3.98e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CD—obesity	3.12e-07	3.98e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—PIK3CA—obesity	3.1e-07	3.96e-06	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—obesity	3.09e-07	3.95e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MYC—obesity	3.08e-07	3.93e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—obesity	3.08e-07	3.92e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—obesity	3.08e-07	3.92e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—LPL—obesity	3.07e-07	3.91e-06	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—obesity	3.05e-07	3.89e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MYC—obesity	3.03e-07	3.87e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—obesity	3.03e-07	3.86e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—obesity	3.03e-07	3.86e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—STAT3—obesity	3.01e-07	3.84e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GPX1—obesity	2.99e-07	3.81e-06	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKT1—obesity	2.99e-07	3.81e-06	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKT1—obesity	2.98e-07	3.8e-06	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKT1—obesity	2.96e-07	3.78e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—STAT3—obesity	2.96e-07	3.78e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—STAT3—obesity	2.96e-07	3.77e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—obesity	2.95e-07	3.77e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK8—obesity	2.95e-07	3.76e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—STAT3—obesity	2.95e-07	3.76e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—NOS3—obesity	2.94e-07	3.75e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3R1—obesity	2.94e-07	3.75e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AKT1—obesity	2.94e-07	3.75e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—STAT3—obesity	2.94e-07	3.74e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—obesity	2.92e-07	3.73e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CD36—obesity	2.91e-07	3.71e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—STAT3—obesity	2.91e-07	3.71e-06	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKT1—obesity	2.9e-07	3.7e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—STAT3—obesity	2.9e-07	3.7e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CB—obesity	2.88e-07	3.68e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—obesity	2.86e-07	3.64e-06	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKT1—obesity	2.85e-07	3.64e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—PIK3CA—obesity	2.83e-07	3.61e-06	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKT1—obesity	2.82e-07	3.59e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—PIK3CA—obesity	2.8e-07	3.57e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MYC—obesity	2.8e-07	3.57e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—obesity	2.79e-07	3.56e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—obesity	2.79e-07	3.55e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PIK3CA—obesity	2.77e-07	3.53e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MTHFR—obesity	2.76e-07	3.52e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MYC—obesity	2.75e-07	3.51e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—obesity	2.75e-07	3.5e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MYC—obesity	2.75e-07	3.5e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—obesity	2.75e-07	3.5e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—obesity	2.74e-07	3.49e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MYC—obesity	2.74e-07	3.49e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—obesity	2.73e-07	3.48e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MYC—obesity	2.73e-07	3.48e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKT1—obesity	2.72e-07	3.47e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—obesity	2.72e-07	3.47e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CB—obesity	2.72e-07	3.47e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARA—obesity	2.71e-07	3.45e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PIK3CA—obesity	2.7e-07	3.45e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MYC—obesity	2.7e-07	3.45e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKT1—obesity	2.7e-07	3.44e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—obesity	2.7e-07	3.44e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MYC—obesity	2.7e-07	3.44e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—STAT3—obesity	2.7e-07	3.44e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—obesity	2.69e-07	3.43e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PIK3CA—obesity	2.69e-07	3.43e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—obesity	2.69e-07	3.43e-06	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AKT1—obesity	2.63e-07	3.36e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AGT—obesity	2.62e-07	3.34e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PIK3CA—obesity	2.62e-07	3.34e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PIK3CA—obesity	2.58e-07	3.28e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKT1—obesity	2.57e-07	3.28e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOE—obesity	2.57e-07	3.28e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AKT1—obesity	2.56e-07	3.26e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CAV1—obesity	2.55e-07	3.25e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PIK3CA—obesity	2.54e-07	3.24e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOA1—obesity	2.54e-07	3.24e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKT1—obesity	2.54e-07	3.23e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MYC—obesity	2.5e-07	3.19e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—obesity	2.5e-07	3.19e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—obesity	2.5e-07	3.19e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—obesity	2.48e-07	3.16e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—obesity	2.4e-07	3.05e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—obesity	2.38e-07	3.04e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PIK3CA—obesity	2.37e-07	3.03e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PIK3CA—obesity	2.34e-07	2.98e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PIK3CA—obesity	2.33e-07	2.97e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PIK3CA—obesity	2.33e-07	2.97e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PIK3CA—obesity	2.32e-07	2.96e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CG—obesity	2.32e-07	2.96e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—obesity	2.32e-07	2.96e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PIK3CA—obesity	2.32e-07	2.95e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKT1—obesity	2.31e-07	2.95e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PIK3CA—obesity	2.29e-07	2.93e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKT1—obesity	2.29e-07	2.92e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.29e-07	2.92e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—obesity	2.28e-07	2.91e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AKT1—obesity	2.26e-07	2.89e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARG—obesity	2.24e-07	2.85e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKT1—obesity	2.21e-07	2.82e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—POMC—obesity	2.21e-07	2.81e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKT1—obesity	2.2e-07	2.8e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—INS—obesity	2.2e-07	2.8e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKT1—obesity	2.14e-07	2.73e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3CA—obesity	2.13e-07	2.71e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKT1—obesity	2.1e-07	2.68e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—obesity	2.1e-07	2.68e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AKT1—obesity	2.08e-07	2.65e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—obesity	2.07e-07	2.64e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—obesity	2.06e-07	2.63e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—obesity	2.06e-07	2.62e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—obesity	2.05e-07	2.62e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CD—obesity	2.04e-07	2.6e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—obesity	2.03e-07	2.59e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—obesity	2.03e-07	2.58e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—obesity	2.01e-07	2.57e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKT1—obesity	1.94e-07	2.47e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3R1—obesity	1.92e-07	2.45e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NOS3—obesity	1.92e-07	2.45e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKT1—obesity	1.91e-07	2.43e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKT1—obesity	1.9e-07	2.43e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AKT1—obesity	1.9e-07	2.43e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKT1—obesity	1.9e-07	2.42e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKT1—obesity	1.89e-07	2.41e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—obesity	1.88e-07	2.4e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKT1—obesity	1.87e-07	2.39e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKT1—obesity	1.87e-07	2.38e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CB—obesity	1.78e-07	2.27e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—obesity	1.76e-07	2.24e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CA—obesity	1.76e-07	2.24e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKT1—obesity	1.74e-07	2.21e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CA—obesity	1.66e-07	2.11e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AKT1—obesity	1.44e-07	1.83e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AKT1—obesity	1.35e-07	1.73e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CA—obesity	1.08e-07	1.38e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AKT1—obesity	8.85e-08	1.13e-06	CbGpPWpGaD
